Literature DB >> 26617715

Ectopic expressed long non-coding RNA H19 contributes to malignant cell behavior of ovarian cancer.

Zhijie Zhu1, Ling Song1, Jun He1, Yanan Sun1, Xiaomei Liu1, Xiaoyan Zou1.   

Abstract

Recent studies have highlighted the role of long non-coding RNAs (lncRNAs) in carcinogenesis and have suggested that genes of this class might be used as biomarkers in cancer. However, whether lncRNAs are involved in ovarian cancer (OC) remains largely unknown. In the present study, we focused on lncRNAH19 and investigated the expression and functional role of H19 in OC. H19 expression was measured in 70 pairs of ovarian cancer tissue samples compared with normal controls by real-time quantitative RT-PCR. The effects of H19 on ovarian cancer cells were studied by RNA interference approach. Apoptosis and cell cycle were analyzed by flow cytometry. Cells viability was evaluated using cell counting Kit-8. Our results demonstrated that that H19 silencing inhibited OV90 and SKOV3 OC cell proliferation in vitro. Further investigation into the mechanisms responsible for the growth inhibitory effects by H19 silencing revealed that its knockdown resulted in the induction of cell cycle arrest and apoptosis through certain cell cycle-related and apoptosis-related proteins. Together, our data suggest that LncRNAH19 plays an important role in OC cell proliferation and contributes to a better understanding of the importance of dysregulated lncRNAs in OC progression.

Entities:  

Keywords:  Ovarian cancer; apoptosis; cell cycle; long non-coding RNA H19; proliferation

Mesh:

Substances:

Year:  2015        PMID: 26617715      PMCID: PMC4637530     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  29 in total

Review 1.  HOTAIR lifts noncoding RNAs to new levels.

Authors:  Caroline J Woo; Robert E Kingston
Journal:  Cell       Date:  2007-06-29       Impact factor: 41.582

Review 2.  Long non-coding RNAs: insights into functions.

Authors:  Tim R Mercer; Marcel E Dinger; John S Mattick
Journal:  Nat Rev Genet       Date:  2009-03       Impact factor: 53.242

3.  The imprinted H19 gene is a marker of early recurrence in human bladder carcinoma.

Authors:  I Ariel; M Sughayer; Y Fellig; G Pizov; S Ayesh; D Podeh; B A Libdeh; C Levy; T Birman; M L Tykocinski; N de Groot; A Hochberg
Journal:  Mol Pathol       Date:  2000-12

4.  The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis.

Authors:  Dalia Barsyte-Lovejoy; Suzanne K Lau; Paul C Boutros; Fereshteh Khosravi; Igor Jurisica; Irene L Andrulis; Ming S Tsao; Linda Z Penn
Journal:  Cancer Res       Date:  2006-05-15       Impact factor: 12.701

5.  H19 mRNA-like noncoding RNA promotes breast cancer cell proliferation through positive control by E2F1.

Authors:  Nathalie Berteaux; Séverine Lottin; Didier Monté; Sébastien Pinte; Brigitte Quatannens; Jean Coll; Hubert Hondermarck; Jean-Jacques Curgy; Thierry Dugimont; Eric Adriaenssens
Journal:  J Biol Chem       Date:  2005-06-28       Impact factor: 5.157

6.  Frequent loss of imprinting of the H19 gene is often associated with its overexpression in human lung cancers.

Authors:  M Kondo; H Suzuki; R Ueda; H Osada; K Takagi; T Takahashi; T Takahashi
Journal:  Oncogene       Date:  1995-03-16       Impact factor: 9.867

7.  Examination of IGF2 and H19 loss of imprinting in bladder cancer.

Authors:  Hyang-Min Byun; Hui-Lee Wong; Elliott Aaron Birnstein; Erika M Wolff; Gangning Liang; Allen S Yang
Journal:  Cancer Res       Date:  2007-11-15       Impact factor: 12.701

8.  H19 and IGF2 gene expression in human normal, hyperplastic, and malignant endometrium.

Authors:  V Tanos; I Ariel; D Prus; N De-Groot; A Hochberg
Journal:  Int J Gynecol Cancer       Date:  2004 May-Jun       Impact factor: 3.437

9.  Loss of H19 imprinting in esophageal cancer.

Authors:  K Hibi; H Nakamura; A Hirai; Y Fujikake; Y Kasai; S Akiyama; K Ito; H Takagi
Journal:  Cancer Res       Date:  1996-02-01       Impact factor: 12.701

10.  The H19 non-coding RNA is essential for human tumor growth.

Authors:  Imad J Matouk; Nathan DeGroot; Shaul Mezan; Suhail Ayesh; Rasha Abu-lail; Abraham Hochberg; Eithan Galun
Journal:  PLoS One       Date:  2007-09-05       Impact factor: 3.240

View more
  32 in total

1.  Long non-coding RNA H19 enhances cell proliferation and anchorage-independent growth of cervical cancer cell lines.

Authors:  Tawin Iempridee
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-04

2.  LncRNA H19-elevated LIN28B promotes lung cancer progression through sequestering miR-196b.

Authors:  Jin Ren; Jinling Fu; Tiangang Ma; Bingdi Yan; Rong Gao; Zhe An; Dan Wang
Journal:  Cell Cycle       Date:  2018-07-23       Impact factor: 4.534

Review 3.  Regulatory role of long non-coding RNAs during reproductive disease.

Authors:  Kangsheng Liu; Xiaodong Mao; Yajun Chen; Taiping Li; Hua Ton
Journal:  Am J Transl Res       Date:  2018-01-15       Impact factor: 4.060

4.  Long non-coding RNAs in ovarian cancer: expression profile and functional spectrum.

Authors:  Selin Oncul; Paola Amero; Cristian Rodriguez-Aguayo; George A Calin; Anil K Sood; Gabriel Lopez-Berestein
Journal:  RNA Biol       Date:  2019-12-17       Impact factor: 4.652

5.  LncRNA H19 promotes proliferation and invasion in A375 human melanoma cell line.

Authors:  Xiaoling Zhu; Wei Li; Qinggang Meng
Journal:  Int J Clin Exp Pathol       Date:  2018-03-01

Review 6.  Long non-coding RNAs: emerging players in osteosarcoma.

Authors:  Zheng Li; Xin Yu; Jianxiong Shen
Journal:  Tumour Biol       Date:  2015-12-30

Review 7.  The long non-coding RNA H19: an active player with multiple facets to sustain the hallmarks of cancer.

Authors:  Clément Lecerf; Xuefen Le Bourhis; Eric Adriaenssens
Journal:  Cell Mol Life Sci       Date:  2019-07-23       Impact factor: 9.261

8.  The long noncoding RNA H19 promotes cell proliferation via E2F-1 in pancreatic ductal adenocarcinoma.

Authors:  Ling Ma; Xiaodong Tian; Feng Wang; Zhengkui Zhang; Chong Du; Xuehai Xie; Marko Kornmann; Yinmo Yang
Journal:  Cancer Biol Ther       Date:  2016-08-29       Impact factor: 4.742

Review 9.  Role of lncRNAs in ovarian cancer: defining new biomarkers for therapeutic purposes.

Authors:  Manish K Tripathi; Kyle Doxtater; Fatemeh Keramatnia; Chidi Zacheaus; Murali M Yallapu; Meena Jaggi; Subhash C Chauhan
Journal:  Drug Discov Today       Date:  2018-04-23       Impact factor: 7.851

Review 10.  The Significance of Long Noncoding RNA H19 in Predicting Progression and Metastasis of Cancers: A Meta-Analysis.

Authors:  Wei Jing; Man Zhu; Xian-Wei Zhang; Zhong-Ya Pan; Shan-Shan Gao; Hu Zhou; Shi-Li Qiu; Chun-Zi Liang; Jian-Cheng Tu
Journal:  Biomed Res Int       Date:  2016-09-08       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.